Moffitt Cancer Center
Tampa, Florida, 33612, United States
NCT Number: NCT06923033
The aim of this study is to update a recently developed study-related smartphone application to reduce cravings to smoke to be an engaging, user-friendly treatment tool, and verify user satisfaction
Looking for future studies?
Notify MeHealthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will download a study app that will allow them to track smoking urges and abstinence. Access to augmented reality will become available after 48 hours of self-reported abstinence.
Time frame: At 1 week
Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale. Scores range from 0 to 100, with higher scores indicating better usability.
Time frame: At 1 week
One Likert scale item will capture participants' satisfaction with the app. The Likert scale is from 1 to 4, with higher score indicating greater satisfaction.
H. Lee Moffitt Cancer Center and Research Institute
Other
Aim 1: Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02779127
Behavior, Smoking
Toulouse, France
View Trial DetailsNCT03978442
Behavior, Mental Disorders
Durham, North Carolina, United States
View Trial DetailsNCT05490927
Behavior, Discrimination, Racial
Houston, Texas, United States
View Trial DetailsNCT03528304
Behavior, Body Weight
View Trial Details